NCT05365581 A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer Status RECRUITING Phase PHASE1
NCT05355701 A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. Status RECRUITING Phase PHASE1
NCT05330429 Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) Status TERMINATED Phase PHASE2
NCT05329766 A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05296005 Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers Status WITHDRAWN Phase PHASE1
NCT05253651 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer Status RECRUITING Phase PHASE3
NCT05047991 Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma Status UNKNOWN Phase PHASE2
NCT05009953 Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer Status TERMINATED Phase PHASE2
NCT05009069 A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04929028 Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04927780 Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04840264 Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction Status RECRUITING Phase PHASE2
NCT04821284 Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04762953 Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04761614 Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT04755543 A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms Status UNKNOWN Phase PHASE1
NCT04752696 Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE2